EUCTR2006-005011-10-IT进行中（未招募）不适用
OW DOSE RITUXIMAB IN THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA. - ND
IVERSITA DEGLI STUDI DI UDINE0 个研究点开始时间: 2006年12月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •AGE OR 16 YEARS OLD; REFRACTORY OR RELAPSED AUTOIMMUNE THROMBOCYTOPENIA; WRITTEN INFORMED CONSENCE.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •AUTOIMMUNE THROMBOCYTOPENIA NEVER TREATED BEFORE; PREGNANCY AND NURSING;HIV, HBV AND HCV POSITIVITY; OTHER SEVERE CONCOMITANTE PATHOLOGIES.
研究者
相似试验
尚未招募
不适用
Rituximab administration for chronic antibody-mediated rejection after kidney transplantatioAntibody-mediated rejection after kidney transplantationJPRN-UMIN000018567Department of Nephrology and Hypertension, Saitama Medical Center, Saitama Medical University1
已完成
不适用
Rituximab in Rheumatoid Arthritis in patients who failed therapy with tumour necrosis factor-blockers: a multi-centre clinical observational real-life study (phase IIIb)Rheumatoid Arthritis (RA)Musculoskeletal DiseasesISRCTN27093749Medical University of Vienna (Austria)20
已完成
不适用
Analysis of Rituximab intensification therapy for low grade B-cell lymphoma refractory to BendamustineJPRN-UMIN000007110Tokyo women's medical university50
进行中（未招募）
1 期
Very low doses of Rituximab for autoimmune diseases, for which rituximab is not approved for - a Pilot TrialAutoimmune-haemolytic AnemiaAntiphospholipid SyndromeImmune-mediated ThrombocytopeniaMedDRA version: 20.0Level: LLTClassification code 10003825Term: Autoimmune hemolytic anemiaSystem Organ Class: 100000154058MedDRA version: 20.0Level: LLTClassification code 10023095Term: ITPSystem Organ Class: 100000157088MedDRA version: 20.0Level: PTClassification code 10002817Term: Antiphospholipid syndromeSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2016-002478-11-ATMedical University of Vienna, Department of Internal medicine I48
进行中（未招募）
不适用
Rituximab in Rheumatoid Arthritis in Patients Who Failed Therapy With TNF-BlockersRheumatoid ArthritisEUCTR2006-000854-32-ATVienna Medical University20